Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 185

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

TET family dioxygenases and DNA demethylation in stem cells and cancers

Open access
An, Jungeun, Rao, Anjana, Ko, Myunggon·2017·Experimental & Molecular Medicine

Abstract

The methylation of cytosine and subsequent oxidation constitutes a fundamental epigenetic modification in mammalian genomes, and its abnormalities are intimately coupled to various pathogenic processes including cancer development. Enzymes of the Ten–eleven translocation (TET) family catalyze the stepwise oxidation of 5-methylcytosine in DNA to 5-hydroxymethylcytosine and further oxidation products. These oxidized 5-methylcytosine derivatives represent intermediates in the reversal of cytosine methylation, and also serve as stable epigenetic modifications that exert distinctive regulatory roles. It is becoming increasingly obvious that TET proteins and their catalytic products are key regulators of embryonic development, stem cell functions and lineage specification. Over the past several years, the function of TET proteins as a barrier between normal and malignant states has been extensively investigated. Dysregulation of TET protein expression or function is commonly observed in a wide range of cancers. Notably, TET loss-of-function is causally related to the onset and progression of hematologic malignancy in vivo. In this review, we focus on recent advances in the mechanistic understanding of DNA methylation–demethylation dynamics, and their potential regulatory functions in cellular differentiation and oncogenic transformation. Proteins that remove chemical tags from DNA play key regulatory roles in cell development and the initiation of cancer. In a review article, Myunggon Ko from the Ulsan National Institute of Science and Technology in South Korea and colleagues describe how enzymes of the Ten-eleven translocation (TET) family reverse the methylation of cytosine in DNA, affecting cellular differentiation, embryonic development and cancer. The researchers detail the mechanisms by which TET proteins remove methyl groups from cytosine residues in a stepwise manner. The absence of functional TET has been implicated in a wide range of human cancers, in particular, cancers of the blood cells. In mouse models, reintroducing TET activity into blood stem cells helped prevent leukemia, suggesting that restoring TET function in people could have therapeutic benefit for cancer patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/emm.2017.5

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 185

Metadata

Authors
An, J., Rao, A., & Ko, M.
Venue
Experimental & Molecular Medicine
Published
2017-04-28
Volume
49
Issue
4
Pages
e323-e323
ISSN
  • 1226-3613 (ISSN-L)
  • 2092-6413
OpenAlex
W2607904823
Cited by
185
References
26
FWCI
6.21
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TET family dioxygenases and DNA demethylation in stem cells and cancers. https://app.cochat.ai/papers/10.1038/emm.2017.5
The paper
An, J., Rao, A., & Ko, M. (2017). TET family dioxygenases and DNA demethylation in stem cells and cancers. Experimental & Molecular Medicine. https://doi.org/10.1038/emm.2017.5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.